Every claim PANCREASaver® makes is backed by literature and regulatory approval — decision-ready information in 30 seconds.
TFDA Medical Device License: No. 007946
Scroll to watch the AUC curve draw — PANCREASaver® reaches 0.95 area under the curve detecting small <2cm tumors.
Figure source: Radiology 2023 (220152) Fig. 3 — nationwide multicenter validation (n=1,473) ｜Article ↗
Five international publications, nine awards, approvals in two markets — PANCREASaver® speaks in verifiable evidence.
5 peer-reviewed papers in Lancet Digital Health, Radiology and other top journals — real clinical validation led by National Taiwan University Hospital.
View 5 papersBreakthrough Device Designation from the U.S. FDA, recognizing technology that can significantly improve early detection of a life-threatening disease. FDA official program page ↗ Media coverage: NTUH breakthrough designation ↗
Device license No. 007946 — the first licensed pancreatic cancer AI-assisted detection device in Taiwan.
10 invention patents across Taiwan (6) and the US (4), written at both system and method level, covering algorithms, imaging and clinical workflow.
View 10 patents
Prof. Wang's team at NTU launches AI early detection research
Prof. Liao of NTUH leads multi-center clinical validation
PanCAD.ai founded; technology licensed for commercialization
First Margulis Award for Taiwan at RSNA
FDA Breakthrough designation; TFDA license No. 007946
Deployed at medical centers, regional hospitals and health centers; 300+ cases
Multi-center validation of AI for early pancreatic cancer detection
Deep learning for pancreatic lesion detection on CT
5 papers total, covering algorithms, clinical validation and workflow
From assessment to go-live, four steps — we walk with you all the way.
We review your imaging equipment, IT systems and clinical workflow to define scope.
Interface with PACS/RIS; AI results flow back automatically — zero disruption to radiology workflow.
Training for radiologists and technologists, plus validation on your institutional data.
Continuous performance monitoring, regular statistical reports and technical support.
Book a 30-minute technical briefing — we'll come with real data.
Book a briefing